# The Role of Endocannabinoids in Insulin Production and Action

> **NCT01517100** · PHASE1 · COMPLETED · sponsor: **National Institute on Aging (NIA)** · enrollment: 45 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **OTHER:** Nabilone
- **DRUG:** CP-945,598
- **OTHER:** hyperglycemic clamp
- **OTHER:** euglycemic-hyperinsulinemic clamp
- **OTHER:** Nabilone

## Key facts

- **NCT ID:** NCT01517100
- **Lead sponsor:** National Institute on Aging (NIA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-05
- **Primary completion:** 2014-10-06
- **Final completion:** 2014-10-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01517100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01517100, "The Role of Endocannabinoids in Insulin Production and Action". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01517100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*